0001209191-22-018614.txt : 20220314
0001209191-22-018614.hdr.sgml : 20220314
20220314181207
ACCESSION NUMBER: 0001209191-22-018614
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220210
FILED AS OF DATE: 20220314
DATE AS OF CHANGE: 20220314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Liao Carrie
CENTRAL INDEX KEY: 0001899817
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40360
FILM NUMBER: 22738032
MAIL ADDRESS:
STREET 1: C/O MIND MEDICINE INC.
STREET 2: ONE WORLD TRADE CENTER, SUITE 8500
CITY: NEW YORK
STATE: NY
ZIP: 10007
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mind Medicine (MindMed) Inc.
CENTRAL INDEX KEY: 0001813814
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1166 ALBERNI STEET
STREET 2: SUITE 1604
CITY: VANCOUVER
STATE: A1
ZIP: V6E 3Z3
BUSINESS PHONE: (212) 220-6633
MAIL ADDRESS:
STREET 1: 1166 ALBERNI STEET
STREET 2: SUITE 1604
CITY: VANCOUVER
STATE: A1
ZIP: V6E 3Z3
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-10
0
0001813814
Mind Medicine (MindMed) Inc.
MNMD
0001899817
Liao Carrie
C/O MIND MEDICINE (MINDMED), INC.
ONE WORLD TRADE CENTER, SUITE 8500
NEW YORK
NY
10007
0
1
0
0
VP, Controller&Acct Principal
Subordinate Voting Shares
2022-02-10
4
A
0
403430
0.00
A
403430
D
Stock Option (Right to Buy)
1.34
2022-02-10
4
A
0
524450
0.00
A
2027-02-09
Subordinate Voting Shares
524450
524450
D
Grant of 403,430 restricted stock units ("RSUs") on February 10, 2022. Each RSU represents a contingent right to receive one subordinate voting share of the Issuer. 25% of the RSUs will vest on October 21, 2022; the remaining RSUs granted will vest with 1/48th of the total shares vesting at the end of each month thereafter for the succeeding 36 months, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date.
The option grant has an exercise price of $1.71 Canadian Dollars. This represents the exercise price in United States Dollars.
25% of the shares underlying the option shall vest and become exercisable on October 21, 2022; the remaining shares underlying the option shall vest and become exercisable with 1/48th of the total shares vesting at the end of each month thereafter for the succeeding 36 months, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date.
/s/ Robert Barrow, Attorney-in-Fact
2022-03-14